Detalhe da pesquisa
1.
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Br J Cancer
; 130(8): 1269-1278, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402342
2.
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.
Ann Oncol
; 31(4): 480-486, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32085892
3.
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group.
Ann Oncol
; 31(2): 246-256, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959341
4.
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies.
Ann Oncol
; 30(9): 1466-1471, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268130
5.
A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group.
Ann Oncol
; 28(5): 922-930, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453700
6.
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.
Ann Oncol
; 28(9): 2077-2085, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28430862
7.
Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma.
Br J Cancer
; 112(1): 86-94, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25422908
8.
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.
Ann Oncol
; 26(3): 463-76, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25015334
9.
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial.
Ann Oncol
; 26(2): 340-7, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403578
10.
Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study.
Ann Oncol
; 24(2): 412-419, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23041588
11.
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma.
Ann Oncol
; 24(6): 1567-73, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406728
12.
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer.
J Clin Oncol
; 41(33): 5080-5089, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967516
13.
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.
Ann Oncol
; 23(2): 450-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21576285
14.
MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer.
ESMO Open
; 7(5): 100559, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029653
15.
Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies.
Ann Oncol
; 21(4): 754-758, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19887466
16.
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.
Ann Oncol
; 21(4): 772-780, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19833818
17.
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial.
Ann Oncol
; 26(5): 1040, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25900678
18.
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.
Ann Oncol
; 21 Suppl 6: vi1-10, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20534623
19.
FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study.
Ann Oncol
; 20(8): 1383-6, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19465426
20.
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study.
Ann Oncol
; 20(6): 1042-7, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19153116